Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chan

Showing results (1461-1470 of 1,535) with videos related to

Pageof 154
Sort By:
Nature Communications|May 27, 2023
macroH2A2 antagonizes epigenetic programs of stemness in glioblastomaAna Nikolic, Francesca Maule, Anna Bobyn, et al.
Nature Immunology|February 5, 2025
The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancerJiacheng He, Xiaolei Chai, Qiansen Zhang, et al.
Nature Communications|October 6, 2020
Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progressionAstrid De Boeck, Bo Young Ahn, Charlotte D'Mello, et al.
Genome Biology|November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signaturesYasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
International Journal of Cancer|October 18, 2016
Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumorsDennis Wang, Nhu-An Pham, Jiefei Tong, et al.
BMC Health Services Research|June 3, 2021
Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trialKimberly A Kaphingst, Wendy Kohlmann, Rachelle Lorenz Chambers, et al.
Nature Communications|February 2, 2021
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitorsCristina Valero, Mark Lee, Douglas Hoen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment SelectionWungki Park, Jiapeng Chen, Joanne F Chou, et al.
Nature Medicine|April 24, 2019
Immunogenic neoantigens derived from gene fusions stimulate T cell responsesWei Yang, Ken-Wing Lee, Raghvendra M Srivastava, et al.
Cancer Cell|April 16, 2021
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacyChirag Krishna, Renzo G DiNatale, Fengshen Kuo, et al.
Pageof 154

Showing results (1461-1470 of 1,535) with videos related to

Sort By:
Pageof 154
Nature Communications|May 27, 2023
macroH2A2 antagonizes epigenetic programs of stemness in glioblastomaAna Nikolic, Francesca Maule, Anna Bobyn, et al.
Nature Immunology|February 5, 2025
The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancerJiacheng He, Xiaolei Chai, Qiansen Zhang, et al.
Nature Communications|October 6, 2020
Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progressionAstrid De Boeck, Bo Young Ahn, Charlotte D'Mello, et al.
Genome Biology|November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signaturesYasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
International Journal of Cancer|October 18, 2016
Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumorsDennis Wang, Nhu-An Pham, Jiefei Tong, et al.
BMC Health Services Research|June 3, 2021
Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trialKimberly A Kaphingst, Wendy Kohlmann, Rachelle Lorenz Chambers, et al.
Nature Communications|February 2, 2021
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitorsCristina Valero, Mark Lee, Douglas Hoen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment SelectionWungki Park, Jiapeng Chen, Joanne F Chou, et al.
Nature Medicine|April 24, 2019
Immunogenic neoantigens derived from gene fusions stimulate T cell responsesWei Yang, Ken-Wing Lee, Raghvendra M Srivastava, et al.
Cancer Cell|April 16, 2021
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacyChirag Krishna, Renzo G DiNatale, Fengshen Kuo, et al.
Pageof 154